We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

006400:KRXSamsung SDI Co., Ltd Analysis

Data as of 2026-07-17 - not real-time

₩434,500.00

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Samsung SDI is trading at 434,500 KRW, well below the analyst consensus target median of 800,000 KRW, implying roughly a 66% upside. The stock sits above its 20‑day SMA (465,500) but below the 50‑day SMA (548,020), while the 200‑day SMA (403,610) provides a long‑term support floor that is comfortably under current levels. Momentum indicators are mixed: RSI is at 41, indicating modest downside pressure, yet the MACD histogram turned positive (1,739) and the MACD line sits above its signal, signaling a tentative bullish shift. Volatility is high at nearly 90% over the past 30 days and beta is 1.77, suggesting the share price will swing sharply with market moves.
Fundamentally, the company reports negative operating (‑6.6%) and profit margins (‑3.3%), a negative free cash flow of –1.5 trillion KRW and a debt‑to‑equity ratio of 47.5, highlighting financial strain. However, the DCF‑derived fair value suggests the market is undervaluing the stock, and the “Extreme Greed” sentiment index (89.13) reflects strong investor appetite. The battery sector’s growth prospects—driven by EV adoption and stationary storage demand—provide a compelling long‑term catalyst despite the current earnings weakness.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Positive MACD crossover and bullish histogram
  • Current price above 200‑day SMA providing support
  • Analyst upside potential of ~66%

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong secular demand for EV and grid‑scale batteries
  • Analyst target median price of 800,000 KRW
  • Improving sentiment reflected by Extreme Greed index

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High debt burden and negative free cash flow
  • Volatile earnings and negative margins
  • Long‑term industry tailwinds but need operational turnaround

Key Metrics & Analysis

Financial Health

Revenue Growth12.60%
Profit Margin-3.34%
P/E Ratio24.9
ROE-2.57%
ROA-2.48%
Debt/Equity47.50
Op. Cash Flow₩705.3B
Free Cash Flow₩-1485815545856
Industry P/E30.9

Technical Analysis

TrendNeutral
RSI41.3
Support₩390,000.00
Resistance₩582,000.00
MA 20₩465,500.00
MA 50₩548,020.00
MA 200₩403,610.00
MACDBullish
VolumeStable
Fear & Greed Index89.13

Valuation

Fair Value₩11,739.28
Target Price₩720,822.56
Upside/Downside65.90%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.77
Volatility89.79%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.